Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial
Critical Care2014Vol. 18(S1)
Citations Over Time
E Giamarellos-Bourboulis, Korina Lymberopoulou, Iraklis Tsangaris, Anastasia Antonopoulou, Androniki Marioli, Λεωνιδία Λεωνίδου, Emmanuel E. Douzinas, Ioannis Koutelidakis, Apostolos Armaganidis
Abstract
A recent randomized trial of our group showed that blind treatment with clarithromycin decreased mortality from septic shock and multiple organ dysfunction, shortened time until resolution of infection in patients with severe sepsis/shock and decreased hospitalization costs [1]. The efficacy of clarithromycin in relation with the type of failing organs is analyzed.
Related Papers
- → Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy(2002)95 cited
- → Clarithromycin Resistance and Eradication of Helicobacter pylori in Children(2001)64 cited
- → Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages(1992)39 cited
- → BIAXIN (Clarithromycin)(2017)2 cited
- Drug utilization of clarithromycin for gastrointestinal disease treatment(2008)